Latest Stories
Guest Editorial
The American Cancer Society’s recent report on the increasing incidence rates of colorectal cancer in young adults once again rang an alarm bell for adults over 45 to get checked, especially if they are having symptoms. But as an oncologist with more than 40 years of experience, I also believe that this should be a clarion call to scientists and researchers, and for regulators at the FDA.
Guest Editorial
In September of 2021, an unprecedented event occurred that may have escaped your notice. The New England Journal of Medicine and over 200 other health care publications simultaneously published joint editorials alerting the greater medical community to the “catastrophic” public health and environmental impacts of climate change.1
Guest Editorial
Cancer specialists like me, whether they are medical, surgical, or radiation oncologists spend our lives treating life threatening disease. We generally have a serious and professional demeanor reflective of the world that we choose to inhabit and the circumstances facing our patients that entrust us with their care.
ClinicalTrials & Tribulations
Technological advances are transforming our understanding of cancer, accelerating the evolution of new treatment approaches. In the past decades, researchers deploying new techniques for analyzing DNA have extended our knowledge of inherited genetic abnormalities that can predispose a person to develop colorectal and other cancers.
